Epin Antoine, Passot Guillaume, Christou Niki, Monneuse Olivier, Mabrut Jean-Yves, Ferrero Pierre-Alexandre, Caudron Sebastien, Pezet Denis, Magnin Benoit, Grange Rémi, Lambert Céline, Williet Nicolas, Flaris Alexandros N, Le Roy Bertrand
Service de chirurgie digestive et cancérologique, CHU Nord Saint Etienne, Avenue Albert Raimond, 42270, Saint-Priest-en-Jarez, France.
Service de chirurgie digestive, Lyon Sud, Hospices civils de Lyon, Chemin du Grand Revoyet, 69310, Pierre-Bénite, France.
World J Surg. 2022 Apr;46(4):784-790. doi: 10.1007/s00268-021-06433-5. Epub 2022 Feb 6.
Gastric pneumatosis (GP) is a rare radiologic finding with an unpredictable prognosis. The aim of this study was to identify mortality risk factors from patients presenting with GP on computed tomography (CT), and to develop a model which would allow us to predict which patients would benefit most from operative management.
Between 2010 and 2020, all CT-scan reports in four tertiary centers were searched for the following terms: "gastric pneumatosis," "intramural gastric air" or "emphysematous gastritis." The retrieved CT scans were reviewed by a senior surgeon and a senior radiologist. Relevant clinical and laboratory data for these patients were extracted from the institutions' medical records.
Among 58 patients with GP, portal venous gas and bowel ischemia were present on CT scan in 52 (90%) and 17 patients (29%), respectively. The 30-day mortality rate was 31%. Univariate analysis identified the following variables as predictive of mortality at the time of the diagnosis of GP: abdominal guarding, hemodynamic instability, arterial lactate level >2 mmol/l, and the absence of gastric dilatation. Multivariable analysis identified the following variables as independent predictors of mortality: arterial lactate level (OR: 1.39, 95% CI: 1.07-1.79) and the absence of gastric dilatation (OR: 0.07, 95% CI: 0.01-0.79). None of the patients presenting with a baseline lactate rate<2 mmol/l died within 30 days following diagnosis, and no more than 17 patients out of 58 had bowel ischemia (29%).
GP could be managed non-operatively, even in the presence of portal venous gas. However, patients with arterial lactate level>2 mmol/l, or the absence of gastric dilation should be surgically explored due to a non-negligible risk of mortality.
胃壁积气(GP)是一种罕见的影像学表现,预后难以预测。本研究的目的是确定在计算机断层扫描(CT)上出现GP的患者的死亡风险因素,并建立一个模型,使我们能够预测哪些患者将从手术治疗中获益最大。
在2010年至2020年期间,在四个三级中心搜索了所有CT扫描报告中的以下术语:“胃壁积气”、“胃壁内气体”或“气肿性胃炎”。检索到的CT扫描由一位资深外科医生和一位资深放射科医生进行复查。从各机构的病历中提取这些患者的相关临床和实验室数据。
在58例GP患者中,CT扫描显示门静脉积气和肠缺血分别见于52例(90%)和17例(29%)。30天死亡率为31%。单因素分析确定以下变量在GP诊断时可预测死亡率:腹部压痛、血流动力学不稳定、动脉血乳酸水平>2 mmol/L以及无胃扩张。多因素分析确定以下变量为死亡率的独立预测因素:动脉血乳酸水平(OR:1.39,95%CI:1.07-1.79)和无胃扩张(OR:0.07,95%CI:0.01-0.79)。基线乳酸率<2 mmol/L的患者在诊断后30天内均未死亡,58例患者中肠缺血患者不超过17例(29%)。
即使存在门静脉积气,GP也可采用非手术治疗。然而,由于存在不可忽视的死亡风险,动脉血乳酸水平>2 mmol/L或无胃扩张的患者应进行手术探查。